Luo et al. [48] reported that the anti-angiogenic and anti-tumor effects of 4-hydroxybenzyl alcohol could, in part, be due to upregulation of nuclear factor erythroid 2-related factor 2 (Nrf2), an emerging regulator of cellular resistance to oxidants, and in part to other antioxidant pathways. This evidence concerns the gene NFE2L2 and neoplasm.